251 new COVID-19 cases were recorded in Armenia in the last 24 hours, bringing the total number of confirmed cases to 8927.
US bio-tech company Moderna Therapeutics signed on May 28 a contract with the Swiss CordenPharma to supply the increased volume of lipids used for the production of experimental vaccine for COVID-19, trying to increase the production capacity aimed at meeting the global demand, Voice of America reports.
460 new cases of the novel coronavirus have been confirmed in Armenia in the past 24 hours, bringing the total number of cases to 8,676, the National Center for Disease Control and Prevention said today.
At the moment there are 4772 active cases. A total of 54,931 tests have been done. 442 new cases were reported today and 32 patients recovered.
6 staffers and 9 children of the Mari Izmirlian Orphanage SNCO have been infected with the novel coronavirus (COVID-19), Armenian labor and social affairs minister’s spokesperson Sona Martirsoyan told Armenpress.
452 new cases of the novel coronavirus have been confirmed in Armenia in the past one day, bringing the total number of infected people to 7,113, the National Center for Disease Control and Prevention said today.
322 new cases of COVID-19 have been recorded in Armenia in the last 24 hours, the NCDC reported. It said that 293 people recovered and were discharged.
335 new COVID-19 cases have been recorded in Armenia in the past 24 hours, Prime Minister Nikol Pashinyan said at the Cabinet meeting.
218 COVID-19 cases have been diagnosed in the past 24 hours in Armenia, the National Center for Disease Control and Prevention reported. The total cumulative number of infection cases has reached 5041.
Modeling for the epidemic progression has significant limitations since it cannot take into consideration different varying factors at the country level which greatly influence the course of the outbreak, and which in turn affect the results of the modeling. In fact, WHO has never recommended publishing any models on pandemic progression for any particular country due to these limitations as well as a multitude of factors (e.g. effect of physical distancing measures on the epidemic progression, cluster outbreaks among high-risk population groups etc.). For this reason, WHO’s position on modeling is very clear – it should only be used as a broad reference, for example in order to estimate the needs of the country based on the ‘worst case scenario’, or ‘community transmission’.
